Research Article

Chronic Condition Clusters and Polypharmacy among Adults

Table 2

Number and weighted percent with polypharmacy. Unadjusted odds ratios and 95% CI from logistic regression on polypharmacy. Medical Expenditure Panel Survey, 2009.

Logistic regression
Wt %OR95% CISig

All2,69225.5
Gender
 Women1,72728.41.41(1.27, 1.56) ***
 Men96522.0
Age in Years
 22–391628.4
 40–4928415.72.03(1.58, 2.61) ***
 50–6495625.13.67(2.93, 4.59) ***
 65–6937137.26.50(5.14, 8.21) ***
 70–7429140.37.40(5.73, 9.56) ***
 75 and older62841.37.70(6.17, 9.60) ***
Race/ethnicity
 White1,58727.2
 African american55623.90.84(0.73, 0.97) *
 Latino38318.40.60(0.51, 0.72) ***
 Other16619.40.65(0.51, 0.82) **
Health insurance
 Private1,33622.4
 Public1,23139.52.26(2.01, 2.55) ***
 Uninsured12510.60.41(0.33, 0.52) ***
Poverty status
 Poor55730.31.53(1.33, 1.76) ***
 Near poor69131.41.62(1.40, 1.86) ***
 Middle income74124.71.16(1.02, 1.32) *
 High income70322.1
Total visits
 1st quartile1135.1
 2nd quartile43313.82.95(2.18, 3.99) ***
 3rd quartile77827.16.88(5.17, 9.15) ***
 4th quartile1,36847.616.77(12.5, 22.4) ***

Note: Based on 10,528 adults alive at the end of 2009, reported having at least one chronic condition (cardio-metabolic, musculoskeletal, or respiratory condition). All analyses accounted for complex survey design of the Medical Expenditure Panel Survey. Asterisks represent statistically significant group differences based on chi-square tests. CM: Cardio-metabolic; Musc.: musculoskeletal; Resp.: respiratory; Wt: weighted; OR: odds Ratio; CI: confidence Interval.
; ; .